These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9039333)

  • 1. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
    Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
    Rodríguez-Arnao J; Jabbar A; Fulcher K; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.
    Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):689-96. PubMed ID: 8736270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.
    Vahl N; Jørgensen JO; Hansen TB; Klausen IB; Jurik AG; Hagen C; Christiansen JS
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):529-36. PubMed ID: 9665673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.
    Wallymahmed ME; Foy P; Shaw D; Hutcheon R; Edwards RH; MacFarlane IA
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):439-46. PubMed ID: 9404442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
    Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance.
    Jørgensen JO; Thuesen L; Müller J; Ovesen P; Skakkebaek NE; Christiansen JS
    Eur J Endocrinol; 1994 Mar; 130(3):224-8. PubMed ID: 8156094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of growth hormone treatment in GH-deficient adults.
    Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
    Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.
    de Boer H; Blok GJ; Voerman B; de Vries P; Popp-Snijders C; van der Veen E
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2069-76. PubMed ID: 7608257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
    Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
    Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
    Vahl N; Juul A; Jørgensen JO; Orskov H; Skakkebaek NE; Christiansen JS
    J Clin Endocrinol Metab; 2000 May; 85(5):1874-81. PubMed ID: 10843168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.